content

BioXcel Therapeutics Announces FDA Clearance of IND Application for BXCL501

BioXcel Therapeutics, Inc , a clinical-stage biopharmaceutical company utilizing artificial intelligence approaches to identify and advance the next wave of medicines in neuroscience and...

Thermo Fisher Scientific Introduces NGS-Based Solution for Expanded Carrier Screening Research

Thermo Fisher Scientific introduced a new next-generation sequencing (NGS)-based solution that enables reproductive health researchers to more efficiently analyze a broad range of key...

Vetter pharma aligns its development service laboratory portfolio

Vetter has brought together its development laboratories in one Ravensburg site end of last year. Designed to improve workflow and enhance customer benefits within...

AIVITA Biomedical completes patient enrollment target in phase 2 GBM trial for glioblastoma

AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, announced that it has reached its patient enrollment target in the company's...

Sanofis phase 2 study of BTK inhibitor, SAR442168 meets primary endpoint to treat MS

The Sanofi phase 2b study evaluating its investigational BTK (Brutons tyrosine kinase) inhibitor (SAR442168), an oral, brain-penetrant, selective small molecule, achieved its primary endpoint. In...

Teva Announces Positive Top-Line Results from AJOVY Clinical Trials in Japan

Teva Pharmaceutical Industries Ltd announced positive results from two Phase 2/3 trials evaluating AJOVYยฎ (fremanezumab) in patients in Japan. AJOVY is under development in...

Aimmune secures $200m funding from Nestle Health Science

Aimmune Therapeutics, Inc. (Nasdaq: AIMT), a biopharmaceutical company developing and commercializing treatments for potentially life-threatening food allergies, today announced that Nestlรฉ Health Science will...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read